Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2014 Sep:25 Suppl 3:iii40-8. doi: 10.1093/annonc/mdu223. Epub 2014 Aug 5.

Authors

J Bellmunt¹, A Orsola², J J Leow¹, T Wiegel³, M De Santis⁴, A Horwich⁵; ESMO Guidelines Working Group

Collaborators

Affiliations

¹ Department of Medical Oncology, University Hospital del Mar-IMIM, Barcelona, Spain Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, USA.
² Department of Urology, Vall d'Hebron University Hospital, Barcelona, Spain.
³ Department of Radio Oncology, University Hospital Ulm, Ulm, Germany.
⁴ Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef- Spital, Vienna, Austria.
⁵ Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK.

PMID: 25096609
DOI: 10.1093/annonc/mdu223

No abstract available

Publication types

Practice Guideline

MeSH terms

Combined Modality Therapy
Follow-Up Studies
Health Planning Guidelines
Humans
Neoplasm Staging
Prognosis
Societies, Medical / standards*
Urinary Bladder Neoplasms / diagnosis*
Urinary Bladder Neoplasms / therapy*